Clinical Trial Update: Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating maintenance S-1 chemotherapy versus observation after adjuvant therapy in patients with resected pancreatic cancer at hig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Pancreatic Cancer, Postoperative Adjuvant Therapy | Phase 4 | Status: NOT_YET_RECRUITING